Taro Pharmaceutical Indus... (TARO)

NYSE: TARO · Real-Time Price · USD

42.98

0.01 (0.02%)

At close: Jun 21, 2024, 7:59 PM

Taro Pharmaceutical Industries Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	362.91M	154.5M	251.13M	605.18M	513.35M	567.45M	576.61M	600.4M	576.76M
Short-Term Investments	516.44M	695.79M	569.61M	418.48M	595.38M	481.88M	846.01M	786.36M	651.87M
Long-Term Investments	457.99M	404.9M	435.19M	557.21M	459.64M	304.32M	225.64M	70.69M	115.17M
Other Long-Term Assets	82.45M	83.15M	6.77M	4.34M	3.51M	1.54M	1.95M	2.58M	2.23M
Receivables	177.46M	241.8M	292.48M	252.86M	262.28M	285.31M	329.42M	470.2M	509.33M
Inventory	204.82M	226.67M	210.44M	180.29M	153.07M	148.08M	144.59M	141.04M	138.55M
Other Current Assets	41.77M	11.72M	14.22M	12.89M	8.84M	8.14M	7.71M	145.31M	226.23M
Total Current Assets	1.3B	1.34B	1.34B	1.47B	1.53B	1.48B	1.9B	2B	1.88B
Property-Plant & Equipment	217.59M	190.14M	199.69M	205.51M	209.96M	206.24M	193.73M	180.09M	159.46M
Goodwill & Intangibles	17.23M	17.23M	71.94M	26.98M	28.85M	29.52M	28M	27.06M	29.57M
Total Long-Term Assets	858.67M	799.09M	838.48M	936.04M	808.65M	652.61M	536.58M	290.73M	310.44M
Total Assets	2.16B	2.14B	2.18B	2.41B	2.34B	2.14B	2.43B	2.29B	2.19B
Account Payables	44.66M	68.48M	68.23M	61.17M	28.86M	35.06M	25.7M	209.84M	245.46M
Deferred Revenue	n/a	903K	5.79M	7.58M	237K	9.44M	3.23M	167K	799K
Short-Term Debt	n/a	1.95M	2.2M	1.69M	1.51M	n/a	n/a	n/a	n/a
Other Current Liabilities	316.44M	314.21M	355.89M	605.86M	192.12M	181.76M	190.06M	-167K	-799K
Total Current Liabilities	361.11M	385.55M	432.12M	676.3M	222.73M	216.82M	215.76M	209.84M	245.46M
Long-Term Debt	n/a	n/a	n/a	n/a	-4.09M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	7.96M	-616K	-919K	-1.09M	2.74M	2.83M	-1.86M	-1.63M	-1.33M
Total Long-Term Liabilities	7.96M	19.11M	32.8M	35.12M	8.76M	7.38M	7.05M	6.11M	5.43M
Total Liabilities	369.06M	404.65M	464.92M	711.42M	231.49M	224.2M	222.81M	215.95M	250.89M
Total Debt	n/a	1.95M	2.2M	1.69M	1.51M	n/a	n/a	n/a	n/a
Common Stock	1.79B	680K	680K	679K	679K	680K	680K	680K	680K
Retained Earnings	n/a	2.41B	2.39B	2.34B	2.73B	2.48B	2.66B	2.45B	1.99B
Comprehensive Income	n/a	-175M	-168.97M	-151.62M	-163.04M	-144.11M	-110.28M	-148.13M	-123.03M
Shareholders Equity	1.79B	1.73B	1.71B	1.7B	2.1B	1.91B	2.21B	2.07B	1.93B
Total Investments	974.43M	1.1B	1B	975.69M	1.06B	786.21M	1.07B	857.05M	767.04M